Press Releases Oculis Holding AG

Equities

OCS

CH1242303498

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-06-03 pm EDT			5-day change	1st Jan Change
11.85 ^USD	+1.28%		-0.42%	+5.52%

May. 30	Oculis Holding AG Announces Board and Committee Appointments	CI
May. 30	Oculis Holding AG announced a financing transaction	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities	Jun. 04	GL
Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board	May. 30	GL
Oculis Holding - Increase in share capital	May. 21	AQ
Oculis updates share capital for its existing at-the-market offering program	May. 17	GL
Oculis : Entry into Sales Agreement with Leerink Partners, LLC - Form 6-K	May. 08	PU
Oculis : Form 6-K	May. 08	PU
Oculis Reports Q1 2024 Financial Results and Provides Company Updates	May. 08	GL
Oculis Announces Completion of Enrollment in Phase 2 Randomized Controlled ACUITY Trial with OCS-05 for Acute Optic Neuritis	May. 08	AQ
Oculis Publishes Invitation to the Annual General Meeting	May. 07	GL
Oculis to Present at Bank of America Global Healthcare Conference	May. 06	AQ
Oculis Publishes Invitation to the Annual General Meeting	Apr. 29	AQ
Oculis Announces Closing of Registered Direct Offering and Commencement of Trading on Nasdaq Iceland Main Market	Apr. 22	GL
Oculis Announces Completion of Oversubscribed $59 Million Registered Direct Offering and Subsequent Listing on Nasdaq Iceland Main Market	Apr. 11	AQ
Oculis Strengthens its Executive Leadership Team with the Appointment of Snehal Shah, Pharm.D. as President of Research & Development	Apr. 10	AQ
Positive Results from Phase 3 OPTIMIZE-1 Trial of Once Daily OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery Presented at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting	Apr. 08	AQ
Oculis to Participate at Upcoming April Investor Conferences	Apr. 04	AQ
Oculis Reports Q4 and Full Year 2023 Financial Results and Update on Company Progress	Mar. 18	AQ
Oculis Provides Updates at R&D Day on Late-Stage Clinical Trials and Announces Key Leadership Appointments	Feb. 28	AQ
Oculis to Present at Upcoming February Investor Conferences	Jan. 29	AQ
Oculis to Host In-Person & Virtual R&D Day in New York on February 28, 2024	Jan. 22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Oculis Holding AG

Equities

OCS

CH1242303498

Press Releases

Filters